TISG's focus on rural hospitals, physician partnerships and HMO status result in limited competition
Key Largo, Fla., Dec. 12, 2008 -- AMI Research, a division of Hawk Associates that provides quality credible analyst reports, announced today that it has initiated research coverage of Tri-Isthmus Group (TIGroup) (Pink Sheets: TISG) with a BUY recommendation. AMI Research projects a near-term price range of $0.56 to $0.71 per diluted share and a long-term target of $1.19 to $1.59.
TIGroup acquires and provides financial, operational and technological services to healthcare facilities located in rural markets. In October 2008, TIGroup became a Medicare Advantage provider, permiting the company to be its own Health Maintenance Organization (HMO). This generates a consistent revenue stream at the beginning of every month through a capped per person payment. The company anticipates enrolling approximately 5,000 patients by 2009.
Longer life expectancies, the company's focus on rural demographics, strategic physician partnerships and increased Medicare spending are some key factors insinuating a favorable outlook for TISG's future revenue growth.
About AMI Research
AMI Research is a leading provider of issuer-paid research coverage and a division of Hawk Associates Inc. AMI Research offers high quality and credible fundamental analysis of promising small companies that do not have traditional Wall Street analyst coverage. These detailed reports provide serious investors with an in-depth understanding of a company and its technology, industry, strategic position, business model, financial history and future prospects.
AMI Research abides by the Best Practice Guidelines Governing Analyst and Corporate Issuer Relationships, developed by the CFA Institute in conjunction with the National Investor Relations Institute (NIRI). The cost of a newly initiated enrollment in a one-year continuing research program is $30,000 prepaid for four research reports. AMI does not accept payment of fees in company shares, and all AMI Research and Hawk Associates personnel are prohibited from owning or trading in securities of covered companies. The views expressed in this report accurately reflect the analyst’s personal views about the subject securities or issuer. Neither the analyst’s compensation nor the compensation received by AMI Research is in any way related to the specific ratings or views contained in this research report.
About Hawk Associates
Since 1995, Hawk Associates has been helping microcap and small companies build valuation, support and credibility on Wall Street through customized, sustainable investor relations strategies. Hawk specializes in developing communications strategies that stand out in a universe of more than 5,000 small and microcap companies on Wall Street. Hawk has nearly 60 years of collective IR experience and serves clients in the United States, the U.K., China and Vietnam.
|
